|
A study has found that "an NHS test to assess a patient's risk of heart attack is worthless," according to the Daily Mail today.
|
|
Main Category: Cardiovascular / Cardiology Also Included In: Primary Care / General Practice Article Date: 15 Nov 2008 A study published on bmj.com finds that the electrocardiograms usually given to people with ...
|
|
The high cost of angioplasty may not justify the marginal benefit, a new study suggests.
|
|
CV Therapeutics Inc. winnowed its loss by 26 percent in the third quarter, the biopharmaceutical company said Thursday, because of improved sales of its angina drug Ranexa and greater royalty and collaboration ...
|
|
Shares of the Palo Alto, Calif.-based company were up 85 cents, or 8.8%, at $10.55. Chronic angina, or debilitating chest pain, affects more than 9 million people in the U.S., according to the company.
|
|
The study involved almost 900 patients from Canada and internationally with documented coronary artery disease and a history of stable angina.
|
|
Thousands of Britons are missing out on an effective treatment for angina - simply because most doctors know nothing about it.
|
|
Results from a late-breaking clinical trial, presented at the 2008 Canadian Cardiology Congress in Toronto, show for the first time that combining the pure heart rate reduction medication ivabradine to current ...
|
|
MONTREAL HEART INSTITUTE LEAD INVESTIGATOR PRESENTS AT LATE BREAKING CLINICAL TRIAL SESSION MONTREAL, Oct.
|
|
Lead investigator, from the Universite de Montreal and the Montreal Heart Institute, presents findings from clinical trial Results from a late-breaking clinical trial, presented at the 2008 Canadian Cardiology ...
|